SelectQuote Faces Significant Stock Drop Following Poor Earnings and DOJ Lawsuit
SelectQuote Inc. (NYSE: SLQT) encountered a wave of investor discontent on May 12, 2025, as its stock plummeted by an alarming 12% after a quarterly earnings report that did not meet market expectations. This decline compounded an already troubling trend as the stock had already shrunk by over 19% a week earlier when the U.S. Department of Justice (DOJ) announced a lawsuit against the insurance brokerage and several prominent health insurance companies. The announcement raised questions about the operational integrity and strategic direction of SelectQuote.
In response to the disappointing quarterly outcome, SelectQuote reported earnings of $0.03 per share, falling short of the anticipated $0.04 per share as outlined by the Zacks Consensus Estimate. Additionally, the company’s revenues registered at $408.16 million, which was below the expected $417.01 million, marking a dip of approximately 2.12%. Such figures signify serious financial difficulties that have led to questions regarding the company's future and sustainability.
The ongoing troubles for SelectQuote were further escalated by the DOJ’s allegations detailed in the lawsuit filed against them on May 1, 2025. The suit accuses SelectQuote, alongside other significant players in the health insurance industry, such as Aetna, Anthem, and Humana, of violating the False Claims Act. Key claims allege that between 2016 and 2021, SelectQuote received sizable compensation from health insurers for enrolling Medicare Advantage (MA) beneficiaries while allegedly failing to provide impartial guidance, consequently leading beneficiaries to options that offered the highest commissions. Moreover, the suit claims that SelectQuote incentivized its sales teams based on commissions, thereby compromising the suitability and appropriateness of the plans they promoted.
Concern surrounding how SelectQuote has operated under these shadows has only grown. Reed Kathrein, a partner from Hagens Berman— the law firm investigating claims against SelectQuote—remarked, “The recent earnings figures reinforce our pre-existing concerns regarding SelectQuote's alleged steering tactics, especially in light of the DOJ's legal scrutiny.” The severe combination of a disappointing financial report and serious legal claims have left investors shaken about the company’s stability and ethical practices.
As the consequences of these issues mount, Hagens Berman encourages affected investors who have experienced significant losses to come forward and submit their details for further investigation. Furthermore, individuals who possess information that could assist in the case are urged to reach out to the firm's attorneys, as the outcome of the investigation could have substantial ramifications for all stakeholders involved.
These events highlight a troubling landscape for SelectQuote and raise alarms about how the company’s previously stable business structure may have been undermined by legal challenges and operational missteps. As scrutiny intensifies, the company must now navigate a complex road ahead to rebuild trust and restore investor confidence. It remains to be seen how SelectQuote will address these concerns moving forward, but there is an urgent need for transparency and action to mitigate the fallout from the current crisis.
Hagens Berman emphasizes that whistleblowers possessing critical, non-public information about SelectQuote may be eligible for the SEC Whistleblower program, potentially securing rewards up to 30% of any recovery efforts by the SEC. This underscores the importance of accountability and the pressing need for integrity across the entire operation if SelectQuote intends to recover from these detrimental circumstances. The focus now shifts towards addressing these challenges effectively, with stakeholders looking for reassurance and stability in the face of adversity.
For investors seeking updates or assistance, further information regarding the ongoing investigations, legal proceedings, or questions can be efficiently addressed by reaching out to Hagens Berman. Following such tumultuous developments, the landscape for SelectQuote remains uncertain, offering a somber reminder of the potential vulnerabilities existing within the financial systems of even well-known firms.
In response to the disappointing quarterly outcome, SelectQuote reported earnings of $0.03 per share, falling short of the anticipated $0.04 per share as outlined by the Zacks Consensus Estimate. Additionally, the company’s revenues registered at $408.16 million, which was below the expected $417.01 million, marking a dip of approximately 2.12%. Such figures signify serious financial difficulties that have led to questions regarding the company's future and sustainability.
The ongoing troubles for SelectQuote were further escalated by the DOJ’s allegations detailed in the lawsuit filed against them on May 1, 2025. The suit accuses SelectQuote, alongside other significant players in the health insurance industry, such as Aetna, Anthem, and Humana, of violating the False Claims Act. Key claims allege that between 2016 and 2021, SelectQuote received sizable compensation from health insurers for enrolling Medicare Advantage (MA) beneficiaries while allegedly failing to provide impartial guidance, consequently leading beneficiaries to options that offered the highest commissions. Moreover, the suit claims that SelectQuote incentivized its sales teams based on commissions, thereby compromising the suitability and appropriateness of the plans they promoted.
Concern surrounding how SelectQuote has operated under these shadows has only grown. Reed Kathrein, a partner from Hagens Berman— the law firm investigating claims against SelectQuote—remarked, “The recent earnings figures reinforce our pre-existing concerns regarding SelectQuote's alleged steering tactics, especially in light of the DOJ's legal scrutiny.” The severe combination of a disappointing financial report and serious legal claims have left investors shaken about the company’s stability and ethical practices.
As the consequences of these issues mount, Hagens Berman encourages affected investors who have experienced significant losses to come forward and submit their details for further investigation. Furthermore, individuals who possess information that could assist in the case are urged to reach out to the firm's attorneys, as the outcome of the investigation could have substantial ramifications for all stakeholders involved.
These events highlight a troubling landscape for SelectQuote and raise alarms about how the company’s previously stable business structure may have been undermined by legal challenges and operational missteps. As scrutiny intensifies, the company must now navigate a complex road ahead to rebuild trust and restore investor confidence. It remains to be seen how SelectQuote will address these concerns moving forward, but there is an urgent need for transparency and action to mitigate the fallout from the current crisis.
Hagens Berman emphasizes that whistleblowers possessing critical, non-public information about SelectQuote may be eligible for the SEC Whistleblower program, potentially securing rewards up to 30% of any recovery efforts by the SEC. This underscores the importance of accountability and the pressing need for integrity across the entire operation if SelectQuote intends to recover from these detrimental circumstances. The focus now shifts towards addressing these challenges effectively, with stakeholders looking for reassurance and stability in the face of adversity.
For investors seeking updates or assistance, further information regarding the ongoing investigations, legal proceedings, or questions can be efficiently addressed by reaching out to Hagens Berman. Following such tumultuous developments, the landscape for SelectQuote remains uncertain, offering a somber reminder of the potential vulnerabilities existing within the financial systems of even well-known firms.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.